EGFR and lung carcinoma: The driver mutations in EGFR, KRAS, TP53, and ALK were found to be highly concordant (>80%) between primary NSCLC and matched BMs 7, suggesting that there must be unique mechanisms underlying the high incidence of BMs in these driver-mutated lung cancers.